Drug-related hepatotoxicity risk in elderly patients with atrial fibrillation: insights from the nationwide Italian START registry
Gianluca Gazzaniga, Danilo Menichelli, Daniela Poli, Gualtiero Palareti et autres
2 citationsScientific Reports
Giovanni Nante
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
28Publications signalées
903Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Atrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and ManagementAntiplatelet Therapy and Cardiovascular DiseasesVitamin K Research StudiesBlood Pressure and Hypertension Studies
Publications récentes
Real-world use of direct oral anticoagulants in atrial fibrillation patients with moderate/severe chronic kidney disease: a propensity score matched analysis from the START registry
Danilo Menichelli, Gianluca Gazzaniga, Daniela Poli, Gualtiero Palareti et autres
2 citationsClinical Research in Cardiology
Atrial Fibrillation, Heart Failure Phenotypes, and Mortality Risk in the Nationwide START Registry: A Propensity Score Matching Analysis
Danilo Menichelli, Emilia Antonucci, Gianluca Gazzaniga, Daniela Poli et autres
6 citationsJournal of the American Heart Association
Statins under-treatment and mortality in patients with atrial fibrillation. Insights from the nationwide START registry
Danilo Menichelli, Emilia Antonucci, Pasquale Pignatelli, Francesco Violi et autres
3 citationsNutrition Metabolism and Cardiovascular Diseases
Thrombocytopenia and Mortality Risk in Patients With Atrial Fibrillation: An Analysis From the START Registry
Daniele Pastori, Emilia Antonucci, Francesco Violi, Gualtiero Palareti et autres
33 citationsJournal of the American Heart Association
P6258Direct oral anticoagulants in non-valvular atrial fibrillation: accuracy of traditional bleeding scores in the elderly
Simone Novello, Annalisa Graceffa, C Ninivaggi, Giada Ida Greco et autres
0 citationsEuropean Heart Journal
P1564Atrial fibrillation and thromboembolic prophylaxis: focus on the frail oldest patient. how net clinical benefit influences anticoagulant therapy
Giada Ida Greco, C Ninivaggi, Annalisa Graceffa, Simone Novello et autres
0 citationsEuropean Heart Journal
Point of Care Testing (POCT) to assess drug concentration in patients treated with non-vitamin K antagonist oral anticoagulants (NOACs)
S. Padayattil Jose, A. Banzato, Paolo Carraro, A. Haleh et autres
11 citationsThrombosis Research
Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism
Raffaele Pesavento, Lucia Filippi, Antonio Palla, A. Visonà et autres
124 citationsEuropean Respiratory Journal
Anthropometric parameters and the incidence of atrial fibrillation in older people: the PRO .V.A study
Caterina Trevisan, Stefania Maggi, Chiara Curreri, Giovanni Nante et autres
6 citationsClinical Cardiology
Consequences of warfarin suspension after major bleeding in very elderly patients with non valvular atrial fibrillation
Giacomo Zoppellaro, Serena Granziera, Giulia Bertozzo, Gentian Denas et autres
9 citationsThrombosis and Haemostasis
Reasons for and consequences of vitamin K antagonist discontinuation in very elderly patients with non‐valvular atrial fibrillation
Giulia Bertozzo, Giacomo Zoppellaro, Serena Granziera, Lucia Marigo et autres
30 citationsJournal of Thrombosis and Haemostasis
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.